Examining Glucagon-Like Peptide-1 Receptor (Glp-1r) Agonists for Central Nervous System Disorders
Proceedings of a Workshop
Mitwirkender: Norris, Sheena M Posey; Pool, Robert; Childers, Eva
Erscheint vorauss. 27. November 2025
23,99 €
inkl. MwSt.
PAYBACK Punkte
12 °P sammeln!
Glucagon-like peptide-1 receptor (GLP-1R) agonists, originally developed for type 2 diabetes patients and popularized by their ability to rapidly reduce body weight in patients with obesity, have recently received a lot of national attention. Repurposing GLP-1R agonists to treat some central nervous disorders is promising, but comparatively understudied. At a September 2024 workshop, the National Academies Forum on Neuroscience and Nervous System Disorders reviewed the current knowledge and research gaps about the mechanisms of action of GLP-1R agonists in the brain, and the evidence of their ...
Glucagon-like peptide-1 receptor (GLP-1R) agonists, originally developed for type 2 diabetes patients and popularized by their ability to rapidly reduce body weight in patients with obesity, have recently received a lot of national attention. Repurposing GLP-1R agonists to treat some central nervous disorders is promising, but comparatively understudied. At a September 2024 workshop, the National Academies Forum on Neuroscience and Nervous System Disorders reviewed the current knowledge and research gaps about the mechanisms of action of GLP-1R agonists in the brain, and the evidence of their clinical efficacy for eating disorders, neurodegenerative diseases, substance use disorders, and pain.
Andere Kunden interessierten sich für
![Cover A Textbook of Physiology. With C.S. Sherrington. Part 3. The Central Nervous System [electronic Resource]](https://bilder.buecher.de/produkte/64/64363/64363371n.jpg "A Textbook of Physiology. With C.S. Sherrington. Part 3. The Central Nervous System [electronic Resource]")
